# States Alert NSC on Pharmaceutical Supply Risks

Missouri and Tennessee Attorneys General Catherine Hanaway and Jonathan Skrmetti joined a coalition of 20 states to formally alert the National Security Council about significant national security and public health risks posed by Chinese-sourced pharmaceutical ingredients infiltrating the U.S. supply chain. The coalition specifically highlights vulnerabilities in FDA oversight, including the "Green List" policy that allows unapproved and potentially counterfeit GLP-1 drug ingredients and peptides to enter the market. This action underscores growing state-level concern over supply chain integrity and calls for enhanced federal safeguards to protect pharmaceutical procurement and public health.

- Procurement professionals should anticipate increased scrutiny and potential regulatory changes affecting sourcing of pharmaceutical ingredients, especially those linked to Chinese suppliers on the FDA Green List.
- Agencies involved in pharmaceutical acquisitions may need to reassess supplier vetting processes and compliance requirements to mitigate risks from unapproved or counterfeit products.
- Contractors and vendors supplying pharmaceutical ingredients should prepare for possible tighter FDA oversight and state-federal coordination aimed at securing supply chains.
- This development signals a heightened focus on supply chain security as a national security priority, influencing future procurement policies and contract evaluations in healthcare and pharmaceutical sectors.

**Jurisdictions:** sled
**Industries:** Healthcare
**Topics:** Regulatory Compliance
**Published:** September 23, 2026

### Government Entities
- Office of the Attorney General of Missouri
- State of Tennessee Attorney General's Office
- Food and Drug Administration (FDA)
- National Security Council (NSC)
- U.S. Department of State

### Vendors
- Harbin Jixianglong Biotech Co., Ltd (Chinese pharmaceutical supplier on FDA Green List)

### Key Quotes
> My office will not stand idly by while Chinese‑affiliated entities tied to fentanyl production are exploiting oversight gaps to push unsafe, unapproved drug ingredients into our supply chain.
> — Catherine Hanaway, Attorney General of Missouri

> Foreign suppliers who exploit weaknesses in our supply chain to import relabeled or adulterated products pose risks to both our public health and our national security.
> — Jonathan Skrmetti, Attorney General of Tennessee

### Sources
- [Missouri Joins 20-state coalition alerting National Security Council to pharmaceuticals exploited by Chinese supply chain | Newstalk KZRG](https://www.newstalkkzrg.com/2026/09/22/missouri-joins-20-state-coalition-alerting-national-security-council-to-pharmaceuticals-exploited-by-chinese-supply-chain) - Newstalk KZRG
- [Tennessee Joins 20-State Coalition Warning of National Security Risks in Pharmaceutical Supply Chain](https://www.tn.gov/attorneygeneral/news/2026/9/23/pr26-38.html) - TN.gov